Free Trial

Microbot Medical (MBOT) Competitors

Microbot Medical logo
$2.54 -0.08 (-3.05%)
Closing price 04:00 PM Eastern
Extended Trading
$2.59 +0.05 (+2.13%)
As of 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MBOT vs. SMLR, NNOX, SMTI, STIM, SNWV, ZIMV, TCMD, NVRO, SKIN, and NYXH

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Semler Scientific (SMLR), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), Nevro (NVRO), Beauty Health (SKIN), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.

Microbot Medical vs.

Semler Scientific (NASDAQ:SMLR) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Semler Scientific has higher revenue and earnings than Microbot Medical. Semler Scientific is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semler Scientific$56.29M8.89$20.58M-$2.61-17.20
Microbot MedicalN/AN/A-$10.74M-$0.65-3.91

Semler Scientific has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500.

Semler Scientific has a net margin of 72.65% compared to Microbot Medical's net margin of 0.00%. Semler Scientific's return on equity of 50.77% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Semler Scientific72.65% 50.77% 47.04%
Microbot Medical N/A -218.30%-158.17%

Semler Scientific currently has a consensus price target of $71.00, indicating a potential upside of 58.16%. Microbot Medical has a consensus price target of $9.00, indicating a potential upside of 254.33%. Given Microbot Medical's higher possible upside, analysts plainly believe Microbot Medical is more favorable than Semler Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Microbot Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Semler Scientific had 6 more articles in the media than Microbot Medical. MarketBeat recorded 8 mentions for Semler Scientific and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 1.05 beat Semler Scientific's score of 0.59 indicating that Microbot Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Semler Scientific
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Microbot Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Microbot Medical received 347 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 70.79% of users gave Microbot Medical an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote.

CompanyUnderperformOutperform
Semler ScientificOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Microbot MedicalOutperform Votes
349
70.79%
Underperform Votes
144
29.21%

Summary

Semler Scientific beats Microbot Medical on 10 of the 15 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$92.40M$4.47B$5.35B$8.38B
Dividend YieldN/A43.64%5.22%4.10%
P/E Ratio-3.1729.4326.8419.71
Price / SalesN/A67.72391.39116.98
Price / CashN/A51.0838.2534.62
Price / Book6.686.236.794.50
Net Income-$10.74M$68.16M$3.23B$248.18M
7 Day Performance3.25%18.33%4.07%1.14%
1 Month Performance13.90%23.04%12.52%15.18%
1 Year Performance156.57%20.61%16.83%6.55%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBOT
Microbot Medical
1.9287 of 5 stars
$2.54
-3.1%
$9.00
+254.3%
+162.1%$92.40MN/A-3.1720Positive News
Earnings Report
SMLR
Semler Scientific
2.5564 of 5 stars
$34.84
+0.1%
$71.00
+103.8%
+78.4%$334.36M$56.29M7.10120Options Volume
Gap Up
High Trading Volume
NNOX
Nano-X Imaging
1.4416 of 5 stars
$5.56
+6.1%
$12.00
+115.8%
-43.7%$321.25M$11.28M-6.54190News Coverage
Upcoming Earnings
Gap Up
SMTI
Sanara MedTech
1.7872 of 5 stars
$34.37
+6.2%
$48.50
+41.1%
-4.6%$305.48M$86.67M-34.7260Earnings Report
Analyst Revision
High Trading Volume
STIM
Neuronetics
1.9202 of 5 stars
$4.14
-6.5%
$5.50
+32.9%
+69.6%$272.47M$74.89M-3.37180
SNWV
SANUWAVE Health
N/A$30.55
+1.5%
N/AN/A$261.17M$32.63M-6.7040
ZIMV
ZimVie
2.2495 of 5 stars
$8.91
+1.7%
$19.50
+118.9%
-47.9%$248.12M$449.75M-0.682,700
TCMD
Tactile Systems Technology
3.409 of 5 stars
$9.72
+1.9%
$16.00
+64.6%
-23.8%$230.03M$292.98M13.89980
NVRO
Nevro
0.193 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-44.4%$224.32M$408.52M-3.091,090News Coverage
SKIN
Beauty Health
0.3638 of 5 stars
$1.76
-5.9%
$2.45
+39.2%
-34.7%$220.43M$322.47M-4.191,030Positive News
Gap Down
High Trading Volume
NYXH
Nyxoah
2.9175 of 5 stars
$5.98
-5.1%
$14.50
+142.5%
-23.0%$203.68M$4.52M-3.20110Earnings Report
Gap Up

Related Companies and Tools


This page (NASDAQ:MBOT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners